Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001304788 | SCV001494087 | benign | Dilated cardiomyopathy 1DD | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002322206 | SCV002610031 | uncertain significance | Cardiovascular phenotype | 2024-09-25 | criteria provided, single submitter | clinical testing | The p.R1057G variant (also known as c.3169C>G), located in coding exon 11 of the RBM20 gene, results from a C to G substitution at nucleotide position 3169. The arginine at codon 1057 is replaced by glycine, an amino acid with dissimilar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV001304788 | SCV002776520 | uncertain significance | Dilated cardiomyopathy 1DD | 2021-11-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV005094370 | SCV005848565 | uncertain significance | not provided | 2024-08-13 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis indicates that this missense variant does not alter protein structure/function |